U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. S1B Testing for Carcinogenicity of Pharmaceuticals
  1. Regulatory Information

GUIDANCE DOCUMENT

S1B Testing for Carcinogenicity of Pharmaceuticals February 1998

Final

S1B Testing for Carcinogenicity of Pharmaceuticals

Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research
Center for Biologics Evaluation and Research

This document provides guidance on approaches for evaluating the carcinogenic potential of pharmaceuticals.


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Division of Dockets Management (HFA- 305)
Food and Drug Administration
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.